MedPath

Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction

Not Applicable
Conditions
Breast Reconstruction
Breast Cancer
Interventions
Procedure: Immediate Breast reconstruction
Registration Number
NCT04808765
Lead Sponsor
University in Zielona Góra
Brief Summary

The study aimed to assess the impact of the use of closed incision negative pressure wound therapy (ciNPWT) after immediate breast reconstruction on the number of surgical-site complications, skin surface temperature, objective elastic and viscoelastic and subjective scar's quality to determine risk factors that could be considered as indications for prophylactic ciNPWT application.

Detailed Description

Breast cancer excluding skin cancer is the most commonly diagnosed cancer after lung cancer among women. In recent years, the incidence rate of breast cancer has been rising by 0,3% annually. Screening tests are designed to diagnose breast cancer in possible early stadium of disease. Rapid diagnosis and efficacy of neoadjuvant and adjuvant therapies influence on immediate breast reconstructions after skin (SSM) and nipple-sparing mastectomies (NSM). The prophylactic methods of reducing a higher wound healing complication rate after neoadjuvant and adjuvant therapies are crucial.

The study aimed to assess the impact of the use of closed incision negative pressure wound therapy (ciNPWT) after immediate breast reconstruction on the number of surgical-site complications, skin surface temperature, objective elastic and viscoelastic and subjective scar's quality to determine risk factors that could be considered as indications for prophylactic ciNPWT application.

The analysis included data from anamnesis, details of performed surgical procedure, measurements of skin surface temperature with Skin-Thermometer® probe, measurements of skin elasticity with Cutometer® probe, and scar assessments according to POSAS v2.0 questionnaire for patient and observer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • >= 18 years of age
  • indications for immediate breast reconstruction
Exclusion Criteria
  • pregnancy or lactation,
  • use of steroids, use of immune modulators known to affect wound healing;
  • tattoos in the area of the incision;
  • breast skin conditions such as cutis laxa;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ST groupImmediate Breast reconstructionA randomized group of patients receiving standard dressing (sterile gauze and medical tape) on closed incision
VAC groupImmediate Breast reconstructionA randomized group of patients receiving negative pressure wound therapy dressing (Avelle-ConvaTec) on closed incision
Primary Outcome Measures
NameTimeMethod
Postsurgical complications - reported for 60 patients1 year

surgical site complications

Secondary Outcome Measures
NameTimeMethod
Subjective examination of scar quality1 year after surgery

POSAS 2.0 (Patient and Observer Scar Assessment Scale) questionnaire for the observer and the patient.

Questions regards painful, itchy scar, difference between scar and normal skin. The min score is 7, the max score is 70. The higher score means better result

Objective examination of scar quality1 year after surgery

measure skin elasticity with Cutometer

Superficial Skin Temperature (SST) of scar, skin next to scar and the second breast1 month after surgery

measure SST with Skin-Thermometer

Subjective quality of life1-2 years after surgery

BREAST-Q reconstruction module and Breast implant illness survey for patients. Questions about self-confidence, comfort, acceptance of new appearance, feeling of implants, breast pain. The min score is 1, the max 3-5 depending on part of questionnaire

Trial Locations

Locations (1)

University in Zielona Gora

🇵🇱

Zielona Gora, Lubuskie, Poland

© Copyright 2025. All Rights Reserved by MedPath